These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


438 related items for PubMed ID: 24444782

  • 1. Prediction of coronary artery disease severity using CHADS2 and CHA2DS2-VASc scores and a newly defined CHA2DS2-VASc-HS score.
    Cetin M, Cakici M, Zencir C, Tasolar H, Baysal E, Balli M, Akturk E.
    Am J Cardiol; 2014 Mar 15; 113(6):950-6. PubMed ID: 24444782
    [Abstract] [Full Text] [Related]

  • 2. CHA2DS2-VASc-HSF score - New predictor of severity of coronary artery disease in 2976 patients.
    Modi R, Patted SV, Halkati PC, Porwal S, Ambar S, Mr P, Metgudmath V, Sattur A.
    Int J Cardiol; 2017 Feb 01; 228():1002-1006. PubMed ID: 27915215
    [Abstract] [Full Text] [Related]

  • 3. CHA2DS2-VASc-HS score in non-ST elevation acute coronary syndrome patients: assessment of coronary artery disease severity and complexity and comparison to other scoring systems in the prediction of in-hospital major adverse cardiovascular events.
    Taşolar H, Çetin M, Ballı M, Bayramoğlu A, Otlu YÖ, Türkmen S, Aktürk E.
    Anatol J Cardiol; 2016 Oct 01; 16(10):742-748. PubMed ID: 27025198
    [Abstract] [Full Text] [Related]

  • 4. The association between asymptomatic coronary artery disease and CHADS2 and CHA2 DS2 -VASc scores in patients with stroke.
    Cha MJ, Lee HS, Kim YD, Nam HS, Heo JH.
    Eur J Neurol; 2013 Sep 01; 20(9):1256-63. PubMed ID: 23560528
    [Abstract] [Full Text] [Related]

  • 5. CHADS2, CHA2DS2-VASc and R2CHADS2 scores predict mortality in patients with coronary artery disease.
    Huang FY, Huang BT, Pu XB, Yang Y, Chen SJ, Xia TL, Gui YY, Peng Y, Liu RS, Ou Y, Chen F, Zhu Y, Chen M.
    Intern Emerg Med; 2017 Jun 01; 12(4):479-486. PubMed ID: 28161883
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the ATRIA, CHA2DS2-VASc, and Modified Scores ATRIA-HSV, CHA2DS2-VASc-HS, for the Prediction of Coronary Artery Disease Severity.
    Yildirim A, Kucukosmanoglu M, Yavuz F, Koyunsever NY, Cekici Y, Dogdus M, Abacioğlu ÖÖ, Kilic S.
    Angiology; 2021 Aug 01; 72(7):664-672. PubMed ID: 33550837
    [Abstract] [Full Text] [Related]

  • 7. Predictive value of CHA2DS2-VASc and CHA2DS2-VASc-HS scores for failed reperfusion after thrombolytic therapy in patients with ST-segment elevation myocardial infarction.
    Kilic S, Kocabas U, Can LH, Yavuzgil O, Çetin M, Zoghi M.
    Cardiol J; 2019 Aug 01; 26(2):169-175. PubMed ID: 29512096
    [Abstract] [Full Text] [Related]

  • 8. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation.
    Letsas KP, Efremidis M, Giannopoulos G, Deftereos S, Lioni L, Korantzopoulos P, Vlachos K, Xydonas S, Kossyvakis C, Sideris A.
    Europace; 2014 Feb 01; 16(2):202-7. PubMed ID: 23813452
    [Abstract] [Full Text] [Related]

  • 9. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
    Tu HT, Campbell BC, Meretoja A, Churilov L, Lees KR, Donnan GA, Davis SM.
    Cerebrovasc Dis; 2013 Feb 01; 36(4):273-80. PubMed ID: 24135809
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of the CHADS2, CHA2DS2-VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: the AMADEUS trial.
    Apostolakis S, Lane DA, Buller H, Lip GY.
    Thromb Haemost; 2013 Nov 01; 110(5):1074-9. PubMed ID: 24048467
    [Abstract] [Full Text] [Related]

  • 12. The CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongation.
    Chan YH, Yiu KH, Lau KK, Yiu YF, Li SW, Lam TH, Lau CP, Siu CW, Tse HF.
    Atherosclerosis; 2014 Dec 01; 237(2):504-13. PubMed ID: 25463082
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical utility of CHADS2 and CHA2DS2-VASc scoring systems for predicting postoperative atrial fibrillation after cardiac surgery.
    Chua SK, Shyu KG, Lu MJ, Lien LM, Lin CH, Chao HH, Lo HM.
    J Thorac Cardiovasc Surg; 2013 Oct 01; 146(4):919-926.e1. PubMed ID: 23628495
    [Abstract] [Full Text] [Related]

  • 15. Pre-admission CHADS2, CHA2DS2-VASc, and R2CHADS2 Scores on Severity and Functional Outcome in Acute Ischemic Stroke with Atrial Fibrillation.
    Tanaka K, Yamada T, Torii T, Furuta K, Matsumoto S, Yoshimura T, Takase K, Wakata Y, Nakashima N, Kira J, Murai H.
    J Stroke Cerebrovasc Dis; 2015 Jul 01; 24(7):1629-35. PubMed ID: 25906940
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. CHADS2, CHA2DS2-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Puurunen MK, Kiviniemi T, Schlitt A, Rubboli A, Dietrich B, Karjalainen P, Nyman K, Niemelä M, Lip GY, Airaksinen KE.
    Thromb Res; 2014 Apr 01; 133(4):560-6. PubMed ID: 24461143
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.